Details for Patent: 7,955,619

Which drugs does patent 7,955,619 protect, and when does it expire?

Patent 7,955,619 protects MORPHABOND ER and ROXYBOND and is included in two NDAs.

This patent has twenty-three patent family members in ten countries.

Summary for Patent: 7,955,619

Title:	Abuse resistant drugs, method of use and method of making
Abstract:	An abuse resistant oral pharmaceutical composition, comprising: a barrier layer, comprising a first polymer; a diffusion layer, comprising a second polymer, substantially covering the barrier layer, wherein the diffusion layer is bonded to the barrier layer and comprises a drug that is substantially homogeneously distributed within the second polymer and diffuses from the diffusion layer within the gastrointestinal (GI) tract; and optionally an expansion layer comprising an expandable polymer, wherein the expansion layer is substantially covered by the barrier layer. Methods of making the same and methods of using the same are also provided.
Inventor(s):	Manish S. Shah, Ray J. Difalco
Assignee:	Abuse Deterrent Pharmaceutical LLC , Ohemo Life Sciences Inc
Application Number:	US12/950,819
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,955,619
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Process; Dosage form;

Drugs Protected by US Patent 7,955,619

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Ohemo Life	MORPHABOND ER	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	206544-001	Oct 2, 2015		DISCN	Yes	No			Y
Ohemo Life	MORPHABOND ER	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	206544-002	Oct 2, 2015		DISCN	Yes	No			Y
Ohemo Life	MORPHABOND ER	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	206544-003	Oct 2, 2015		DISCN	Yes	No			Y
Ohemo Life	MORPHABOND ER	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	206544-004	Oct 2, 2015		DISCN	Yes	No			Y
Protega Pharms	ROXYBOND	oxycodone hydrochloride	TABLET;ORAL	209777-001	Apr 20, 2017		RX	No	No			Y

International Family Members for US Patent 7,955,619

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2008286914
Australia	2009282376
Australia	2015200009
Australia	2017200414
Australia	2019200895